Limonene (10 μg/mL) presents a neuroprotective potential against exposed primary cortical neurons to Aβ1–42 oligomers (in vitro model of AD) by mitigating ROS generation and the potassium channel (KV3.4) hyperfunction [148]. Here, KCNC4 is linked to Alzheimer disease.